INTERNATIONAL PATENT: BAYER AKTIENGESELLSCHAFT FILES APPLICATION FOR "STABLE SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING CRYSTALLINE FORM OF HER2/MUTEGFR INHIBITOR AND PROCESS FOR ITS PREPARATION"

GENEVA, March 9 -- BAYER AKTIENGESELLSCHAFT (Kaiser-Wilhelm-Allee 151373 Leverkusen) filed a patent application (PCT/EP2025/074336) for "STABLE SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING CRYSTALLINE FORM OF HER2/MUTEGFR INHIBITOR AND PROCESS FOR ITS PREPARATION" on Aug 27, 2025. With publication no. WO/2026/047022, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIBANC, Rok (c/o Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 151373 Leverkusen), MANGAL, Haress Ahmad (c/o Bayer Aktiengesellschaft, Kaiser-Wilhelm-Allee 1513...